Patent · US Active

Diffusing alpha-emitter radiation therapy with enhanced beta treatment

US12246191B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2023
Grant dateMar 11, 2025
Priority date
Expiry dateOct 4, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/1098
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An interstitial source including a base suitable for implanting in a tumor and radioactive atoms of one or more isotopes, which are attached to the base. The radioactive atoms have a radon release rate of at least 0.5 micro-Curie (μCi) per centimeter length, and emit beta radiation achieving at 2 millimeters from the base an asymptotic dose of at least 10 Gy. Additionally, the ratio between the beta radiation asymptotic dose at a distance of 2 millimeters from the device, to the radon release rate, is greater than 15 Gy/(microcurie/cm).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.